| Submissions received by the Committee |
|
1
|
Medibank Private
|
|
2
|
Consumers Health Forum of Australia
|
|
3
|
Australian Medical Association
|
|
4
|
Australian Private Hospitals Association
|
|
5
|
Australian Orthopaedic Association Limited
|
|
6
|
NHMRC
|
|
7
|
Brandwood Biomedical Pty Ltd
|
|
8
|
St Jude Medical Australia Pty Ltd
|
|
9
|
Mrs Therese Wood
|
|
10
|
Max Boccardo Associates Pty Ltd
|
|
11
|
Stryker Australia, Supplementary Submission
|
|
12
|
Medical Technology Association of Australia
|
|
13
|
Boston Scientific Australia New Zealand
|
|
14
|
Medtronic Australasia Pty Ltd, Supplementary
Submission
|
|
15
|
Sportsmed-SA
|
|
16
|
AusBiotech Ltd
|
|
17
|
IVD Australia Limited
|
|
18
|
Therapeutic Goods Administration
|
|
19
|
Cancer Council WA
|
|
20
|
Australian Health Insurance Association
|
|
21
|
Department of Innovation, Industry, Science and
Research
|
|
22
|
Name Withheld
|
|
23
|
Name Withheld
|
|
24
|
Name Withheld
|
|
25
|
Name Withheld
|
|
26
|
Name Withheld
|
|
27
|
Name Withheld
|
|
28
|
Johnson & Johnson Medical Pty Ltd
|
|
29
|
Mr Robert Lugton, Attachment 1, Attachment 2,
Supplementary Submission,
|
|
30
|
Australian Dental Industry Association
|
|
31
|
Name Withheld
|
|
32
|
Mr Stuart Cain, Supplementary Submission
|
|
33
|
Logic Appeal
|
|
34
|
Name Withheld
|
| |
|
| Additional Information Received |
|
1
|
Medical Technology Association of Australia, Opening
Statement tabled at the public hearing in Canberra on 27 September 2011
|
|
2
|
Consumers Health Forum of Australia, Opening Statement
tabled at the public hearing in Canberra on 27 September 2011
|
|
3
|
Johnson & Johnson Medical Pty Ltd, Opening
Statement tabled at the public hearing in Canberra on 27 September 2011
|
|
4
|
Stryker South Pacific, Additional Information received
7 October 2011
|
|
5
|
Clerk's Advice, dated 18 October 2011.
|
| |
|
| Correspondence |
|
1
|
Response from Australian Orthopaedic Association to potential adverse comment (sub 29). Received 9 September 2011
|
|
2
|
Response from St Jude Medical to potential adverse
comment arising from evidence of Ms K Carey at public hearing of 27 September
2011
|
| |
|
| Answers to Questions on Notice |
|
1
|
Consumers Health Forum of Australia, Answers to Questions on Notice following the public hearing on 27 September 2011, received 4 October 2011
|
|
2
|
Medical Technology Association of Australia, Answers
to Questions on Notice following the public hearing on 27 September 2011,
received 14 October 2011
|
|
3
|
Johnson & Johnson Medical Australia, Answers to
Questions on Notice following the public hearing on 27 September 2011,
received 14 October 2011
|
|
4
|
Australian Orthopaedic Association, Answers to
Questions on Notice following the public hearing on 27 September 2011,
received 17 October 2011
|
|
5
|
Australian Orthopaedic Association, Additional Answers
to Questions on Notice following the public hearing on 27 September 2011,
received 19 October 2011
|
|
6
|
Department of Health and Ageing, Answers to Questions
on Notice following the public hearing on 27 September 2011, received 25
October 2011
|
|
7
|
Department of Health and Ageing, Answers to Questions
on Notice asked on 17 October 2011, received 27 October 2011
|
|
8
|
Department of Health and Ageing, Answers to Questions
on Notice asked on 17 October 2011, received 31 October 2011
|
|
9
|
National Joint Replacement Registry, Australian
Orthopaedic Association Limited, Answers to Questions on Notice asked on 21
October 2011, received 25 October 2011.
|